As a potential treatment of COVID-19: Montelukast
Cihan Fidan, Ayşe Aydoğdu
Topics & Concepts
MontelukastCoronavirus disease 2019 (COVID-19)AntagonistOxidative stress2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)LeukotrieneCytokineMedicineReceptor antagonistReceptorInflammationPharmacologyImmunologyDiseaseInternal medicineVirologyInfectious disease (medical specialty)AsthmaOutbreakAsthma and respiratory diseasesCOVID-19 Clinical Research StudiesNeutrophil, Myeloperoxidase and Oxidative Mechanisms